Monday, June 15, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Partners Group Lifts $1.5 Billion Real Estate Secondaries Fund as Insiders Inject CHF 20 Million into Beaten-Down Stock

Rodolfo Hanigan by Rodolfo Hanigan
June 15, 2026
in Analysis, European Markets, Market Commentary
0
Partners Group Stock
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

A Swiss asset manager under siege from a US short seller is fighting back on two fronts — with its own cash and a fresh private-market fund. Partners Group has launched a $1.5 billion real estate secondaries program, securing $650 million in commitments at its first close, even as the company denies claims that its open-ended Evergreen structures face a freeze. The move comes as management pours roughly CHF 20 million of personal capital into the firm’s own shares, signaling confidence in the face of a 30% year-to-date slide.

The turmoil traces back to early June, when Partners Group capped quarterly redemptions at 5% for its $8.6 billion Global Value SICAV after withdrawal requests surged to nearly 10% of net asset value. The so-called “gate” spooked retail investors, but the company stresses that the vehicle continues to distribute cash from portfolio companies — 15% last year and 8% so far in 2026. Three other Evergreen funds are also experiencing above-average outflows. Management categorically denies any plan to halt redemptions completely.

Short seller Grizzly Research has piled on, alleging that the Evergreen funds are overvalued by as much as 40% and that some holdings are booked incorrectly. Partners Group has branded the claims defamatory and filed a lawsuit. The attack adds pressure to a share price already trading at 767.00 euros, dangerously close to the 52-week low of 733.00 euros hit in early June. The stock’s relative strength index has sunk to 28.7, deep in oversold territory, and its distance from the 200-day moving line has widened to over 25%.

Should investors sell immediately? Or is it worth buying Partners Group?

Behind the headline numbers, the client split tells a more nuanced story. Roughly 80% of Partners Group’s assets under management come from institutional investors, who tend to be stickier. The redemption wave is concentrated among the 20% retail client base that uses the Evergreen open-end structures. As a result, the core institutional business remains resilient, and the company still forecasts gross new money of $26 billion to $32 billion for the full year. Management does acknowledge a headwind of 1% to 2% from the Evergreen turbulence in the second half.

Founder Fredy Gantner has described the selloff as a “massive overreaction” while conceding communication missteps. To back up that conviction, the firm opened an extraordinary trading window for insiders, leading to the CHF 20 million in purchases. The next major data point arrives on July 15, 2026, when Partners Group updates its assets under management. If institutional inflows keep the growth trajectory stable, analysts see a fundamental base for a re-rating. For now, the oversold RSI and the new $1.5 billion real estate secondaries program offer tactical support — provided the stock can hold above the 733.00 euro floor.

Ad

Partners Group Stock: Buy or Sell?! New Partners Group Analysis from June 15 delivers the answer:

The latest Partners Group figures speak for themselves: Urgent action needed for Partners Group investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 15.

Partners Group: Buy or sell? Read more here...

Tags: Partners Group
Rodolfo Hanigan

Rodolfo Hanigan

Related Posts

Outlook Therapeutics Stock
Analysis

Outlook Therapeutics Insider Bets $5 Million as FDA Clears Path for Eye Drug

June 15, 2026
AST SpaceMobile Stock
Analysis

AST SpaceMobile’s Orbital Test: The Satellites That Must Deliver on $1.2 Billion in Carrier Promises

June 15, 2026
Qualcomm Stock
AI & Quantum Computing

Qualcomm Faces a Defining Moment on June 24 as Data Center Ambitions and AI-PC Dominance Converge

June 15, 2026
Next Post
Bitcoin Stock

Bitcoin's Split Screen: Miners Retreat as Institutions Dig In

Nvidia Stock

Nvidia’s Vera-Rubin Architecture Hits Full Production Amid Capital Rotation to SpaceX

Circus Stock

Circus SE’s Defense-Driven Pivot Collides with Dilution Fears as Production Targets Ramp Up

Recommended

American Express Stock

American Express Doubles Down on Premium Strategy with Card Revamp and Partnerships

9 months ago
Nvidia Stock

Nvidia Stock: China Shift Sparks Investor Concerns

10 months ago
Walgreens Stock

Walgreens Ownership Shift Sparks Industry Transformation

7 months ago
Axon Enterprise Stock

Axon Enterprise’s Bold AI Acquisition Rattles Investors

9 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Outlook Therapeutics Insider Bets $5 Million as FDA Clears Path for Eye Drug

AST SpaceMobile’s Orbital Test: The Satellites That Must Deliver on $1.2 Billion in Carrier Promises

Qualcomm Faces a Defining Moment on June 24 as Data Center Ambitions and AI-PC Dominance Converge

Peace Deal, New Fed Chair, and the Broadening Trade

IonQ’s Nine-Code Feat Highlights Quantum Hardware Edge, but Shareholder Vote Looms Large

The Regress Trap: Why German Employers Who Skip Workplace Safety Inspections Risk Financial Ruin

Trending

Silber Preis Stock
Commodities

Peace Pact Reverses Silver’s 40% Slide, Lifting the Metal Above $70 on Rate and Industry Hopes

by SiterGedge
June 15, 2026
0

A dramatic turnaround in the Middle East has pulled silver out of a five-week tailspin. The agreement...

Adobe Stock

Adobe’s $500M AI Milestone Can’t Hide the Quiet ARR Revision That’s Spooking Investors

June 15, 2026
Northern Resources Stock

Northern Star Rides Gold Wave as Activist Pressure Mounts

June 15, 2026
Outlook Therapeutics Stock

Outlook Therapeutics Insider Bets $5 Million as FDA Clears Path for Eye Drug

June 15, 2026
AST SpaceMobile Stock

AST SpaceMobile’s Orbital Test: The Satellites That Must Deliver on $1.2 Billion in Carrier Promises

June 15, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Peace Pact Reverses Silver’s 40% Slide, Lifting the Metal Above $70 on Rate and Industry Hopes
  • Adobe’s $500M AI Milestone Can’t Hide the Quiet ARR Revision That’s Spooking Investors
  • Northern Star Rides Gold Wave as Activist Pressure Mounts

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com